INTRODUCTION
============

The first report of acute coronary syndrome in the context of allergies was described in 1950 by Pfistero in a 49-year-old man after treatment with beta-lactam antibiotics for 4 days.^([@r1])^ In 1991, Kounis described, for the first time, "allergic angina syndrome", which is characterized by chest pain and allergic skin reaction, accompanied by classic clinical and laboratory findings of myocardial infarction caused by inflammatory mediators released during the allergic reaction.^([@r2]-[@r4])^ Kounis syndrome is subdivided into three types: type 1 results from coronary spasms in normal coronary arteries; type 2 results from spasms or plaque rupture in coronary arteries with previous atherosclerosis; and type 3 results from a hypersensitivity reaction that leads to the thrombosis of a previously implanted pharmacological stent.^([@r5])^

CLINICAL CASE
=============

The patient was a 73 years old female who was leucodermic and who had a known personal history of arterial hypertension, type 2 diabetes mellitus treated with insulin, dyslipidemia, and cerebrovascular disease. The patient denied known drug allergies. She visited the emergency department for productive cough with purulent sputum and fever (38.1°C) with 5 days of evolution. The increase in inflammatory parameters determined analytically and the condensation of the left lower lobe determined by radiology favored the diagnosis of community-acquired pneumonia. She was prescribed amoxicillin/clavulanic acid, and the first administration was by the intravenous route in the emergency department. Approximately one minute after the drug was injected, the patient exhibited a generalized skin rash and an altered state of consciousness, with peripheral oxygen saturation in room air of 67%, blood pressure 87×50 mmHg, and heart rate of 110bpm. She was treated with 2mg clemastine and 200mg hydrocortisone and unfavorably progressed to cardiorespiratory arrest, with subsequent pulse recovery after advanced life support, orotracheal intubation and mechanical ventilation. Electrocardiography showed evidence of ST segment elevation in the inferior territory ([Figure 1](#f1){ref-type="fig"}). Urgent coronarography was performed, revealing diffuse atherosclerotic disease, with the absence of obstructive lesions ([Figure 2](#f2){ref-type="fig"}). Spontaneous resolution of ST-T segment elevation was also observed in the hemodynamic room. The following laboratory results were obtained: troponin I peak, 2,046µg/L; total creatine kinase (CK), 647U/L; and CK-MB, 55U/L. After contact, the family mentioned a previous allergy to penicillin, which the patient was unaware of. In the first 6 hours after shock, the tryptase level was 132ng/mL (strongly positive). Considering the context of being administered amoxicillin/clavulanic acid, the patient was diagnosed with Kounis syndrome type 2. The patient remained under mechanical ventilation for 29 hours, with good subsequent clinical evolution. She was discharged with a recommendation to avoid beta-lactam antibiotics and was referred for immunotherapy.

Figure 1Electrocardiogram performed immediately after drug administration, with ST segment elevation in the inferior territory.

Figure 2Coronarography revealed diffuse atherosclerotic disease without obstructive lesions.

DISCUSSION
==========

Allergy to beta-lactam antibiotics is the most common cause of adverse drug reactions mediated by specific immunological mechanisms.^([@r6])^ This is the most frequently reported drug allergy, with the prevalence varying between 5% and 10%. Recent studies show that 95% of patients with a history of penicillin allergy are not in fact allergic.^([@r7])^ Anaphylaxis, a measured allergic IgE reaction (type TH2), occurs through exposure to specific allergens, which induce a coordinated allergic reaction, releasing acute mediators of the inflammatory response. Mast cells are the main cells involved in allergic reactions and are present in the intima layer of the coronary arteries and atherosclerotic plaques. Given an allergic insult, they release endogenous mediators such as histamine, tryptase, leukotrienes and cytokines.^([@r8])^ In cases of sudden chest pain associated with symptoms of allergy or anaphylaxis, the possibility of Kounis syndrome should always be considered.^([@r9])^ Elevated serum tryptase levels indicate the activation of mast cells, supporting the diagnosis of anaphylaxis; however, negative values do not exclude it.^([@r10])^ The approach to patients with acute coronary syndrome in the context of an allergic reaction should be directed not only to the coronary event but also to the allergic reaction that induces it.^([@r11])^ Because vasospasm is the primary mechanism, nitrates and calcium channel blockers should be considered as first-line therapy.^([@r2])^ Corticosteroids are safe agents and play an important role in the treatment of allergic reactions and allergic acute coronary syndrome; however, they are associated, in some cases, with cardiac aneurysms and rupture of the ventricular wall.^([@r12])^ Adrenaline is the basis of anaphylaxis treatment; however, its use in Kounis syndrome can aggravate ischemia and induce coronary vasospasm and tachyarrhythmia.^([@r2])^ The use of acetylsalicylic acid and heparins is controversial due to their high allergenic power.^([@r13])^

CONCLUSION
==========

Kounis syndrome is most likely a common disease; however, it is underdiagnosed. It is a complex acute coronary syndrome, the pathophysiology of which is still not fully known. Timely treatment improves patient prognosis and should be directed to the hypersensitivity reaction and coronary event. More studies are needed to establish whether the use of adrenaline in these patients is safe.
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